Table 3.
PBAC score about menstrual blood volume of patients
| PBAC | Early-stage endometrial carcinoma | ||
|
| |||
| Before treatment | After 3 months of treatment | After 6 months of treatment | |
|
| |||
| The control group (n=25) | 153.36±18.52 | 66.25±8.36 | 38.61±6.25 |
| The combination group (n=31) | 157.64±17.38 | 53.35±7.26 | 30.23±6.02 |
| χ2/t | 0.8897 | 5.2199 | 5.0912 |
| P-value | 0.3776 | <0.0001 | <0.0001 |
|
| |||
| PBAC | Atypical endometrial hyperplasia | ||
|
| |||
| Before treatment | After 3 months of treatment | After 6 months of treatment | |
|
| |||
| The control group (n=20) | 128.64±15.23 | 54.6±9.26 | 29.62±6.57 |
| The combination group (n=27) | 129.56±15.33 | 40.25±8.26 | 20.36±6.23 |
| χ2/t | 0.2039 | 5.5933 | 4.9229 |
| P-value | 0.8393 | <0.0001 | <0.0001 |